Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-085818
Filing Date
2026-03-02
Accepted
2026-03-02 17:31:01
Documents
108
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amrn-20251231.htm   iXBRL 10-K 4832006
2 EX-4.4 amrn-ex4_4.htm EX-4.4 155389
3 EX-21.1 amrn-ex21_1.htm EX-21.1 22578
4 EX-23.1 amrn-ex23_1.htm EX-23.1 8773
5 EX-31.1 amrn-ex31_1.htm EX-31.1 16732
6 EX-31.2 amrn-ex31_2.htm EX-31.2 17095
7 EX-32.1 amrn-ex32_1.htm EX-32.1 13582
8 GRAPHIC img242934008_0.gif GRAPHIC 152371
9 GRAPHIC img242934008_1.gif GRAPHIC 56907
  Complete submission text file 0001193125-26-085818.txt   20239177

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20251231.xsd EX-101.SCH 2178408
111 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20251231_htm.xml XML 4327541
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21392 | Film No.: 26709673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)